President Trump appointed a new batch of members to PCAST, mostly wealthy tech figures and investors rather than scientists, reflecting an administration stance that has been perceived as hostile to science. This composition could lead to policy recommendations heavily influenced by technology industry perspectives over scientific expertise. Content creators should be aware of the potential shift in focus from evidence-based policies towards more commercially driven technological advancements.
Read the full article at Ars Technica
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
11
Comments
Ali NematiWritten by Ali
